srxhealth.com (SRXH) Quarterly EPS earnings growth

Symbol and logo of brand srxhealth.com (SRXH)

The quarterly EPS growth rate demonstrates the dynamics of SRx Health Solutions Inc. (SRXH), with the indicator holding at 99.00. Canadian management is scaling its network of clinics and pharmacies for patients with severe pathologies. Flawless cold chain logistics and premium care ensure high levels of trust. Operations within North America guarantee a neutral backdrop and protection from external sanctions.

SRXH: SRx Health Solutions Year-over-year earnings per one share growth for the last 12 months 05/01/2025 - 11/17/2026

srxhealth.com (SRXH) - metric breakdowns and financial figures

- share price and expert price forecast:
Initial company analysis:SRx Health Solutions Inc.
Flagship merchandise of SRx Health Solutions Inc.

SRx Health Solutions Inc. (SRXH) proprietary infusion centers ensure high patient loyalty within the consolidated rare drug sector, directly impacting profit scalability. The quarterly EPS change trend reflects the recovery rate of net income per share, allowing investors to identify an entry point with a sufficient margin of safety and avoid purchasing the asset at the indicator's peak.

Who SRx Health Solutions Inc. competes with

VRTX: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Alnylam Inc. (ALNY)|INSM (Insmed) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months UTHR (United Therapeutics Corporation)|Year-over-year net earnings per share growth for the last 12 months BMRN (BioMarin)|BBIO (BridgeBio Pharma) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth BGM (BGM Group Ltd)|COGT (Cogent Bio) - Year-over-year net earnings per share trend for the last twelve months|Xeris Biopharma - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months KROS (Keros Therapeutics)|ARCT: Quarterly EPS earnings growth|Eton Pharmaceuticals Inc (ETON) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Kamada Corp|FULC: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Abeona Therapeutics, Inc. (ABEO)|Year-over-year net earnings per share growth for the last 12 months Mereo BioPharma Group plc MREO|Year-over-year earnings per share growth for the last twelve months Protalix BioTherapeutics PLX|Quarterly EPS earnings growth Pliant Therapeutics PLRX|appliedtherapeutics.com - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months RNTX (Rein Therapeutics, Inc.)|GELS: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Aytu BioPharma, Inc. (AYTU)|CMMB (Chemomab Therapeutics Ltd) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months PLRZ|Quarterly EPS earnings growth AEZS|Year-over-year earnings per share growth for the last twelve months CYTH (Cyclo Therapeutics, Inc)|Inozyme Pharma - Year-over-year net earnings per share growth for the last 12 months|Reneo Pharmaceuticals, Inc. (RPHM) - Earnings per share growth in annualized terms for the last twelve months|COSCIENS Bio - Quarterly EPS earnings growth